Indian pharma exports drop 40% in downturn

The economic downturn in the U.S. has hurt the pharmaceuticals industry worse than any other export sector in the Indian economy. Drug exports dropped almost 40 percent between October 2008 and the end of February 2009 as Indian companies lose relative share to other emerging-market competitors. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.